Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1980-5-23
pubmed:abstractText
The effect of route of administration, dosage, and number of boosts employed during immunization with the polymyxin-release form of Escherichia coli heat-labile (LT) enterotoxin on the degree and duration of protection afforded was evaluated in rats which were challenged by the ligated loop technique. Increasing the boosting dosage by fivefold from 50 to 250 mug resulted in a marked increase in protection against challenge with toxin in rats immunized either just by the parenteral route (i.p./i.p.) or by a parenteral prime, followed by peroral boosts (i.p./p.o.) in rats pretreated with cimetidine to ablate gastric secretions; such was not the case, however, even with a 50-fold increase in dosage in rats immunized just by the peroral route (p.o./p.o.). Four weekly peroral boosts were required to achieve the strongest degree of protection. Increasing the boosting dosage also increased the degree of protection against challenge with viable LT(+)/ST(-) and LT(+)/ST(+) strains (ST indicates heat-stable enterotoxin) in rats immunized by the i.p./p.o., but not by the i.p./i.p., route; no protection was evident against an LT(-)/ST(+) strain. Protection was lost within 3 weeks after immunization in rats immunized by the i.p./i.p. route. In contrast, protection was extended over the 3-month observation period in those immunized by the i.p./p.o. route; the degree of protection was enhanced in rats which received an additional boost at 2 months. These observations establish the fact that immunization with LT is similar to that with cholera toxin in that arousal of the local immune intestinal response by means of peroral immunization provides maximal extended protection.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-1097335, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-16558081, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-197173, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-23336, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-319105, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-326677, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-332637, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-336542, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-346481, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-361578, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-37162, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-378831, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-378842, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-399324, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-4560748, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-457257, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-4582639, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-4592974, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-4609828, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-4919579, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-4932837, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-670885, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-69630, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-711314, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-72361, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-781145, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-83301, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-864285, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-89088, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-89089, http://linkedlifedata.com/resource/pubmed/commentcorrection/6987180-894085
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0019-9567
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
81-6
pubmed:dateRevised
2010-9-13
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Influence of route of administration on immediate and extended protection in rats immunized with Escherichia coli heart-labile enterotoxin.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.